ACADIA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD

Saturday, August 18, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW ORLEANS, Aug. 17, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they

have until September 17, 2018 to file lead plaintiff applications in a securities class action lawsuit against ACADIA Pharmaceuticals Inc. (NasdaqGS: ACAD), if they purchased the
Company's securities between April 29, 2016 and July 9, 2018, inclusive (the "Class Period").  This action is pending in the United States District Court for the Southern District of California.

Get Help

ACADIA investors should visit us at https://www.claimsfiler.com/cases/view-acadia-pharmaceuticals-inc-securities-litigation-1  or call to speak to our claim center toll-free at (844) 367-9658.  

About the Lawsuit

ACADIA and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On July 9, 2018, a report published by the Southern Investigative Reporting Foundation highlighted problems associated with the Company's sole drug, Nuplazid, a treatment for Parkinson's disease, as well as the Company's growth strategies that "have attracted intense regulatory scrutiny for other drug companies" including "dispensing wads of cash to doctors to incentivize prescription writing and downplaying mounting reports of patient deaths."

On this news, the price of ACADIA's shares plummeted $1.21/share, or 6.8%, to close at $16.63/share on July 9, 2018.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

 

Cision View original content:http://www.prnewswire.com/news-releases/acadia-pharmaceuticals-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-acadia-pharmaceuticals-inc---acad-300698976.html

SOURCE ClaimsFiler



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store